Osteoporosis management in older patients who experienced a fracture

Figures & data

Table 1 Descriptive analysis of post-fracture health care by sex, age, and comorbid conditions

Category	Individuals who sustained a fracture (N=1,219)
		Treated or screened (%)	No intervention (%)	All (%)
Age, years	67–75	9.11	38.06	47.17
	76–85	9.02	28.47	37.49
	>86	2.87	12.47	15.34
Sex**	Female	17.06	50.21	67.27
	Male	3.94	28.79	32.73
Diabetes	No	17.23	63.41	80.64
	Yes	3.77	15.59	19.36
Cancer	No	17.56	68.66	86.22
	Yes	3.45	10.34	13.78
CKD	No	20.75	76.70	97.45
	Yes	0.25	2.30	2.55

Note:

** P<0.01.

Abbreviation: CKD, chronic kidney disease.

Figure 1 PHM2 – osteoporosis management in older patients, experiencing a fracture from February 02, 2013 to July 31, 2014.

Abbreviations: n, number of patients; w/o, without.

Table 2 PHM2 – osteoporosis management in older patients, experiencing a fracture from June 01, 2013 to November 11, 2014

	Age at onset	Sex		Race
		Female	Male	Am Indian	Asian	Black	Other	White
Min	67	67	67	67	68	67	67	67
First quartile	71	71	70	67.5	71	71	70.5	71
Median	76	77	75	68	73	76.5	78	76
Mean	77.11	77.76	75.78	70	76.8	77.6	79.03	76.99
Third quartile	83	83	81	71.5	83	84	87	82
Max	102	102	96	75	95	102	97	101
Count	1,219	820	399	3	15	86	59	1,056

Abbreviations: Min, minimum; Max, maximum.

Figure 2 PHM2 – osteoporosis management in older patients, experiencing a fracture (top ten treatments) from June 01, 2013 to November 11, 2014.

Abbreviation: BMD, bone mineral density.

Figure 3 PHM2 – osteoporosis management in older patients, experiencing a fracture from June 01, 2013 to November 11, 2014.

Note: Living female and male at least 67 years old, who suffered a fracture within the 18 months (shown in red and green), and have received bone mineral density testing or osteoporosis medication afterward (shown in green).